Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital

Amanda J Shillingford1, Marianne M Glanzman, Richard F Ittenbach

  • 1Division of Cardiology, Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA. shillingford@email.chop.edu

Pediatrics
|April 3, 2008
PubMed

Insights

School-aged survivors of complex congenital heart disease often experience inattention and hyperactivity, with nearly half requiring remedial school services. No perioperative factors were linked to these neurodevelopmental outcomes, highlighting the need for ongoing screening.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Outcomes
  • Congenital Heart Disease

Background:

  • Growing interest in neurodevelopmental outcomes for school-age survivors of cardiac surgery.
  • Focus on children aged 5-10 who underwent newborn surgery for complex congenital heart disease.
  • Assessment of risk factors for inattention, hyperactivity, and remedial school service use.

Purpose of the Study:

  • To characterize neurodevelopmental outcomes in school-age children with complex congenital heart disease.
  • To identify risk factors associated with inattention and hyperactivity.
  • To determine the prevalence of remedial school service utilization.

Main Methods:

  • Cross-sectional analysis of 109 children (5-10 years old) post-newborn cardiac surgery.
  • Utilized parent and teacher questionnaires for academic performance and general health.
  • Assessed inattention and hyperactivity using standardized scales (ADHD Rating Scale-IV, Behavior Assessment System for Children).

Main Results:

  • 49% of children received remedial academic services; 15% were in special education.
  • Clinically significant inattention and hyperactivity scores were 3-4 times higher than general population rates.
  • 30% of parents reported high-risk inattention scores, 29% for hyperactivity.

Conclusions:

  • A significant proportion of children with complex congenital heart disease are at risk for inattention and hyperactivity.
  • Nearly half of the cohort utilized remedial school services.
  • No perioperative factors were statistically associated with adverse neurodevelopmental outcomes or service use, underscoring the need for continued monitoring.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...